Ads
related to: cancer cells, anti-cancer treatment- Dosing & Administration
Learn about dosing and
administration now
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Dosing & Administration
Search results
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to...
FierceBiotech· 1 hour agoThis story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team....
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Bone Cancer Breakthrough: UCL’s New T-Cell Therapy Shows Promise
SciTechDaily· 20 hours agoA new immunotherapy developed at UCL using engineered immune cells has shown promising preclinical...
Cancer treatment may work best at the right time of day
Futurity· 23 hours agoThe circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy,...
Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology
FierceBiotech· 23 minutes agoThis story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....
...Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer...
FOX21 Colorado Springs· 6 days agoSHANGHAI, May 24, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer ...
New immunotherapy could treat cancer in the bone
Medical Xpress· 20 hours agoOsteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...
...IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate ...
WROC Rochester· 14 hours agoFood and Drug Administration (FDA) for clinical trials of 225Ac-FL-020, its PSMA-targeted...
From Robust Response to Rapid Resistance
MedPage Today· 6 days agoDemonstrating efficacy across multiple tumor types, there is no question that ICIs have revolutionized our approach to treatment and are arguably the...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 6 days agoThe firm and its scientific collaborators detailed the development, training, and initial validation of the platform this month in Cancer Cell, noting that ...